Optimal Power on Left Atrial Wall on Esophagus in Radiofrequency Catheter Ablation for Atrial Fibrillatio
Not Applicable
- Conditions
- atrial fibrillationD001281
- Registration Number
- JPRN-jRCT1072230115
- Lead Sponsor
- Okamatsu Hideharu Hideharu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Patients undergoing first radiofrequency catheter ablation for atrial fibrillation.
Exclusion Criteria
Patients participating in other clinical trials.
Patients with a history of catheter ablation and/or surgery of atrial fibrillation.
Patients with left ventricular ejection fraction less than 35 percent.
Patients with left atrial diameter greater than 55 millimeters.
Patients with persistent atrial fibrillation lasting more than three years.
Patients with a history of surgical or catheter intervention for valvular heart disease.
Patients with severe valvular heart disease
Patients with a history of esophageal varices
Patients with active malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Residual conduction gap on esophagus after linear radiofrequency application for left atrial wall on the esophagus.
- Secondary Outcome Measures
Name Time Method Esophageal lesion classified by Kansas City classification.<br>Gastric hypomotility<br>Residual conduction gap after ipsilateral circumferential linear radiofrequency application around the pulmonary vein.<br>The time needed to complete linear radiofrequency application around the pulmonary vein<br>Procedure-related complication